ETON
ETON
NASDAQ · Pharmaceuticals

Eton Pharmaceuticals Inc

$56.46
+9.31 (+19.75%)
As of Nov 7, 10:21 PM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target -78.9% upside
Low Target $8.04
Average Target $11.93
High Target $13.91
Current Price $56.46
Current
$56.46
Target
$11.93
$8.04 $11.93 avg $13.91
Scenario Analysis
Bear Case
$8.04
-85.8%
Low target
Base Case
$11.93
-78.9%
Avg target
Bull Case
$13.91
+-75.4%
High target
Risk/Reward
0.9x
Unfavorable
Price in Context
52-Week High
$66.37
-14.9% from high
52-Week Low
$14.27
+295.7% from low
Target vs 52W High
$11.93
-82.0% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 37 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 70% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 34 38% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 41% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 22 41% $209.87 +164.3%